Original Research
Accepted on 28 Nov 2024
Factors influencing vancomycin trough concentration in burn patients: a single center retrospective study
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1377930
Type at least 3 characters
324 articles
Articles
Review
Accepted on 27 Nov 2024
Anti-HSV-1 agents, An update
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1451083
Original Research
Accepted on 26 Nov 2024
Which fluoroquinolone is safer when combined with bedaquiline for tuberculosis treatment: Evidence from FDA Adverse Event Reporting System(FAERS)database from 2013 to 2024
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1491921
Original Research
Accepted on 26 Nov 2024
The clinical features and risk factors of Coagulopathy Associated with Cefoperazone/sulbactam: a nomogram prediction model
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1505653
Original Research
Accepted on 26 Nov 2024
Alhagi maurorum extract in combination with lytic phage cocktails: A promising therapeutic approach against biofilms of multi-drug resistant P. mirabilis
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1483055
Review
Accepted on 25 Nov 2024
Clade Ib: A New Emerging Threat in the Mpox Outbreak
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1504154
Original Research
Accepted on 21 Nov 2024
Proteomic study of the inhibitory effect of Tannic acid on MRSA biofilm
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1413669
Original Research
Accepted on 20 Nov 2024
Signal Detection and Analysis of Adverse Events Associated with Genvoya® based the FAERS Database
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1439781
Review
Published on 20 Nov 2024
Natural compounds in the fight against Staphylococcus aureus biofilms: a review of antibiofilm strategies
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1491363
- 311 views
Original Research
Published on 18 Nov 2024
Comparative bactericidal activity of four macrolides alone and combined with rifampicin or doxycycline against Rhodococcus equi at concentrations achievable in foals
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1458496
- 354 views
Original Research
Published on 15 Nov 2024
Population pharmacokinetics of rilpivirine following oral administration and long-acting intramuscular injection in real-world people with HIV
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1437400
- 280 views
Original Research
Published on 13 Nov 2024
Low-dose trimethoprim-sulfamethoxazole treatment for Pneumocystis pneumonia: a systematic review and meta-analysis
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1422490
- 226 views
Original Research
Accepted on 12 Nov 2024
Impact on parasitemia, survival time and pro-inflammatory immune response in mice infected with Plasmodium berghei treated with Eleutherine plicata
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1484934
Review
Accepted on 12 Nov 2024
Voriconazole: A review of adjustment programs guided by therapeutic drug monitoring
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1439586
Correction
Published on 06 Nov 2024
Corrigendum: ArboItaly: leveraging open data for enhanced arbovirus surveillance in Italy
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1517547
- 229 views
Review
Published on 06 Nov 2024
COVID-19 vaccines: current and future challenges
in Pharmacology of Infectious Diseases
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1434181
- 845 views